Price
Financials
Standalone, Rs crore| Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 5.12 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 5.41 | 2.23 | 0.70 | 0.44 | 1.17 | 0.31 | 0.30 | 0.34 |
| Operating Profit | -0.29 | -1.24 | -0.70 | -0.44 | -1.17 | -0.31 | -0.30 | -0.34 |
| OPM % | -5.66% | -125.25% | ||||||
| Other Income | 0.12 | 0.07 | 0.06 | 0.10 | 0.13 | 0.04 | 0.04 | 0.02 |
| Interest | 1.72 | 1.71 | 1.73 | 1.73 | 1.69 | 1.22 | 1.23 | 1.27 |
| Depreciation | 1.72 | 1.72 | 1.74 | 1.74 | 1.70 | 1.72 | 1.74 | 1.74 |
| Profit before tax | -3.61 | -4.60 | -4.11 | -3.81 | -4.43 | -3.21 | -3.23 | -3.33 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -3.61 | -4.60 | -4.11 | -3.81 | -4.43 | -3.21 | -3.23 | -3.33 |
| EPS in Rs | -1.50 | -1.91 | -1.71 | -1.59 | -1.84 | -1.34 | -1.34 | -1.39 |
| Mar 2006 6m | Sep 2007 18m | Sep 2008 | Mar 2010 18m | Mar 2011 | Mar 2012 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 55 | 165 | 57 | 38 | 28 | 26 | 0 |
| Expenses | 59 | 198 | 66 | 55 | 45 | 29 | 2 |
| Operating Profit | -3 | -33 | -9 | -17 | -16 | -2 | -2 |
| OPM % | -6% | -20% | -17% | -44% | -58% | -8% | |
| Other Income | 1 | 42 | 6 | 15 | -11 | 1 | 0 |
| Interest | 5 | 13 | 10 | 3 | 7 | 7 | 5 |
| Depreciation | 4 | 10 | 7 | 12 | 22 | 9 | 7 |
| Profit before tax | -11 | -13 | -21 | -17 | -57 | -17 | -14 |
| Tax % | 0% | 0% | 0% | 0% | 14% | 0% | |
| Net Profit | -11 | -14 | -21 | -17 | -64 | -17 | -14 |
| EPS in Rs | -8.79 | -7.08 | -26.76 | -7.16 | -5.91 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | -22% | -100% | ||
| Compounded Profit Growth | % | % | 6% | 12% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | % | % | % |
| Mar 2006 | Sep 2007 | Sep 2008 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|
| Equity Capital | 17 | 17 | 24 | 24 | 24 | 24 |
| Reserves | -9 | -9 | 15 | -2 | -66 | -83 |
| Borrowings | 106 | 85 | 64 | 57 | 60 | 60 |
| Other Liabilities | 33 | 62 | 16 | 26 | 47 | 56 |
| Total Liabilities | 147 | 154 | 119 | 106 | 65 | 57 |
| Fixed Assets | 83 | 75 | 77 | 75 | 57 | 48 |
| CWIP | 0 | 0 | 6 | 4 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 64 | 79 | 36 | 27 | 8 | 9 |
| Total Assets | 147 | 154 | 119 | 106 | 65 | 57 |
| Mar 2006 | Sep 2007 | Sep 2008 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | -1 | 3 | -6 | 3 | 2 | 7 |
| Cash from Investing Activity | -0 | -2 | -15 | -1 | -0 | 0 |
| Cash from Financing Activity | -1 | -2 | 22 | -3 | -2 | -7 |
| Net Cash Flow | -2 | -1 | 1 | -1 | -0 | 0 |
| Free Cash Flow | -1 | 1 | -21 | 2 | 1 | 7 |
| CFO/OP | 15% | -8% | 66% | -19% | -12% | -350% |
| Mar 2006 | Sep 2007 | Sep 2008 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|
| Debtor Days | 210 | 50 | 7 | 1 | 4 | 0 |
| Inventory Days | 118 | 72 | 55 | 75 | 126 | 195 |
| Days Payable | 234 | 129 | 114 | 469 | 249 | 426 |
| Cash Conversion Cycle | 93 | -7 | -53 | -393 | -119 | -230 |
| Working Capital Days | 146 | 21 | 75 | -75 | -497 | -643 |
| ROCE % | -18% | -11% | -23% | -78% | -108% |
Fundamentals
Market Cap₹ Cr.
Current Price₹ 2.14
Book Value₹ -24.6
ROCE-108 %
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-100%
Compounded Profit Growth (TTM)12%
Standalone figures.
Profitability
Operating margin (excl. other income)-19.67%
Operating margin (incl. other income)5.84%
EBITDA margin-1.39%
Pre-tax margin-9.41%
Net profit margin-9.41%
ROE-176.43%
ROCE-0.53%
ROA-9.01%
ROIC (approx.)-10.06%
Tax rate-0.44%
Other income / net worth568.46%
Growth
Sales growth (latest year)197.96%
Per share
EPS (TTM)Rs -9.28
EPS (latest year)Rs -8.08
EPS (latest quarter)Rs -1.92
Book value per shareRs 4.43
Sales per shareRs 98.64
Cash flow per shareRs 1.53
Free cash flow per shareRs 4.18
Efficiency
Asset turnover1.08x
Fixed asset turnover2.22x
Inventory turnover5.51x
Inventory days66 days
Debtor days50 days
Debtors turnover7.32x
Creditor days426 days
Cash conversion cycle-230 days
Working capital days-643 days
Leverage
Total debtRs 85 Cr
Cash and bankRs 0 Cr
Net debtRs 84 Cr
Debt to equity11.41x
Interest coverage-1.44x
Owners' fund to total sources4.83%
Debt to assets55.11%
Cash flow
Cash from Operating Activity (latest year)Rs 3 Cr
Cash from Investing Activity (latest year)Rs -2 Cr
Cash from Financing Activity (latest year)Rs -2 Cr
Net Cash Flow (latest year)Rs -1 Cr
Free cash flow (latest year)Rs 7 Cr
FCFE (approx.: FCF + change in debt)Rs -14 Cr
Sales to cash flow64.33x
Statement figures
Net sales (TTM)Rs 165 Cr
Net sales (latest year)Rs 165 Cr
Operating profit excl. other income (latest year)Rs -33 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -2 Cr
PBDT (TTM)Rs -9 Cr
Profit before tax (TTM)Rs -16 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs -16 Cr
Net profit (latest year)Rs -14 Cr
Net profit (latest quarter)Rs -3 Cr
Depreciation (TTM)Rs 7 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 6 Cr
Cost of goods sold (latest year)Rs 163 Cr
Total expenditure (latest year)Rs 198 Cr
Total income (latest year)Rs 208 Cr
Share capitalRs 17 Cr
ReservesRs -9 Cr
Shareholders' fundsRs 7 Cr
Total assetsRs 154 Cr
Net blockRs 75 Cr
InvestmentsRs 0 Cr
ReceivablesRs 23 Cr
InventoryRs 30 Cr
Other liabilitiesRs 62 Cr
Shares outstanding (crore)1.68
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 5 of 8| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Dec 2014Sales ₹0 Cr.
Net loss ₹3 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of KDL Biotech Ltd?
KDL Biotech Ltd (532291) has a market capitalisation of Rs Cr. at the close.
What were KDL Biotech Ltd's latest quarterly results?
In the Dec 2014 quarter, KDL Biotech Ltd sales was Rs 0 Cr with a net loss of Rs 3 Cr.